Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stem Cell Infusion”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02659943
What this trial is testing

T Cells Expressing a Fully-human AntiCD19 Chimeric Antigen Receptor for Treating B-cell Malignancies

Who this might be right for
Lymphoma, B-CellLymphoma, Non-hodgkins
National Cancer Institute (NCI) 27
Early research (Phase 1)Ended earlyNCT01551043
What this trial is testing

Allo CART-19 Protocol

Who this might be right for
Acute Lymphocytic Leukemia
University of Pennsylvania 2
Early research (Phase 1)Ended earlyNCT05350163
What this trial is testing

T-cell Receptor α/β Depleted Donor Lymphocyte Infusion

Who this might be right for
Lymphoid Leukemia, AcuteMyeloid MalignancyPlasma Cell Tumor
Guenther Koehne 11
Testing effectiveness (Phase 2)Ended earlyNCT04390152
What this trial is testing

Safety and Efficacy of Intravenous Wharton's Jelly Derived Mesenchymal Stem Cells in Acute Respiratory Distress Syndrome Due to COVID 19

Who this might be right for
Acute Respiratory Distress Syndrome
BioXcellerator 6
Testing effectiveness (Phase 2)Study completedNCT05292625
What this trial is testing

Stem Cell Infusion in the Treatment of Patients with Neurological Sequelae After Ischemic Stroke

Who this might be right for
Ischemic Stroke
Vinmec Research Institute of Stem Cell and Gene Technology 48
Testing effectiveness (Phase 2)UnknownNCT01496339
What this trial is testing

Human Menstrual Blood-derived Mesenchymal Stem Cells Transplantation in Treating Type 1 Diabetic Patients

Who this might be right for
Type 1 Diabetes Mellitus
S-Evans Biosciences Co., Ltd. 50
Testing effectiveness (Phase 2)WithdrawnNCT05333029
What this trial is testing

Extracorporeal Photopheresis and Mesenchymal Stem Cell Infusion for GVHD

Who this might be right for
Graft Versus Host Disease
Molly Gallogly
Testing effectiveness (Phase 2)Study completedNCT00497757
What this trial is testing

Induction of Donor Specific Tolerance in Recipients of Cardiac Allografts by Donor Stem Cell Infusion

Who this might be right for
Heart Transplantation
Suzanne T. Ildstad 62
Testing effectiveness (Phase 2)UnknownNCT05250362
What this trial is testing

Ex Vivo Expanded NK Cells Infusion Decrease Relapse Post Hematopoietic Stem Cell Transplantation

Who this might be right for
Hematologic Malignancy
Sichuan University 56
Testing effectiveness (Phase 2)UnknownNCT04551443
What this trial is testing

WJMSCs Anti-inflammatory Therapy in Acute Myocardial Infarction

Who this might be right for
Acute Myocardial Infarction
Navy General Hospital, Beijing 200
Early research (Phase 1)Looking for participantsNCT06221553
What this trial is testing

Safety and Efficacy of Loco-regional B7H3 IL-7Ra CAR T Cell in DIPG

Who this might be right for
DIPG Brain TumorDiffuse Intrinsic Pontine Glioma
Chulalongkorn University 9
Testing effectiveness (Phase 2)Study completedNCT04331405
What this trial is testing

Allogeneic Cord Blood Cells for Adults With Severe Acute Contusion Spinal Cord Injury

Who this might be right for
Spinal Cord Contusion
Sklifosovsky Institute of Emergency Care 20
Early research (Phase 1)Ended earlyNCT01274377
What this trial is testing

Trial of CMV Specific DLIs From 3-6/6 HLA Matched Family Member Following Nonmyeloablative Allo SCT

Who this might be right for
Cytomegalovirus Infections
Nelson Chao 5
Early research (Phase 1)Looking for participantsNCT05018845
What this trial is testing

Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for CKD

Who this might be right for
Chronic Kidney Diseases
The Foundation for Orthopaedics and Regenerative Medicine 20
Testing effectiveness (Phase 2)Study completedNCT01827579
What this trial is testing

Infusion of Depleted T Cells Following Unrelated Donor Stem Cell Transplant (ICAT)

Who this might be right for
Haematological Malignancies
University College, London 37
Not applicableStudy completedNCT02193880
What this trial is testing

Safety of Post-transplant Alpha-beta Depleted T-cell Infusion Following Haploidentical Stem Cell Transplant (Haplo SCT)

Who this might be right for
Hematologic NeoplasmsGraft-Versus-Host Disease
Ayman Saad 7
Early research (Phase 1)Looking for participantsNCT05016804
What this trial is testing

Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell IV Infusion for Systemic Sclerosis

Who this might be right for
Systemic Sclerosis
The Foundation for Orthopaedics and Regenerative Medicine 20
Testing effectiveness (Phase 2)Ended earlyNCT01310114
What this trial is testing

Study of Human Placenta-derived Cells (PDA001) to Evaluate the Safety and Effectiveness for Patients With Ischemic Stroke

Who this might be right for
Stroke, AcuteMiddle Cerebral Artery StrokePosterior Cerebral Artery Stroke
Celularity Incorporated 44
Testing effectiveness (Phase 2)Ended earlyNCT05447663
What this trial is testing

Siremadlin Alone and in Combination With Donor Lymphocyte Infusion in Acute Myeloid Leukemia Post-allogeneic Stem Cell Transplant

Who this might be right for
Acute Myeloid LeukemiaAllogeneic Stem Cell Transplantation
Novartis Pharmaceuticals 8
Early research (Phase 1)Ended earlyNCT02675556
What this trial is testing

Allogeneic Human Mesenchymal Stem Cells (hMSCs) Infusion in Patients With Treatment Resistant Depression

Who this might be right for
Treatment Resistant Depression
Joshua M Hare 1
Next Page